SK Bioscience Wins Patent Case Against Moderna in S. Korea
SEOUL, April 23 (Korea Bizwire) – SK bioscience Co., the biopharmaceutical arm of South Korea’s SK Group, said Wednesday it has achieved a “final victory” in a patent invalidation case against Moderna, the global developer of the messenger-RNA (mRNA) COVID-19 vaccine. SK bioscience filed a nullity suit in 2023 challenging Moderna’s patent on modified nucleosides, [...]